One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Hydroxychloroquine and lupus flare: a good drug, but we need to do better
Mary K Crow, Kyriakos A Kirou
doi : 10.1136/annrheumdis-2021-221590
March 2022 - Volume 81 - 3
Time to reconsider what Global Burden of Disease studies really tell us about low back pain
Chris Maher, Giovanni Ferreira
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis
Peter C Grayson, Cristina Ponte, Ravi Suppiah, Joanna C Robson, Anthea Craven, Andrew Judge, Sara Khalid, Andrew Hutchings, Raashid A Luqmani, Richard A Watts, Peter A Merkel
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis
Joanna C Robson, Peter C Grayson, Cristina Ponte, Ravi Suppiah, Anthea Craven, Andrew Judge, Sara Khalid, Andrew Hutchings, Richard A Watts, Peter A Merkel, Raashid A Luqmani
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis
Ravi Suppiah, Joanna C Robson, Peter C Grayson, Cristina Ponte, Anthea Craven, Sara Khalid, Andrew Judge, Andrew Hutchings, Peter A Merkel, Raashid A Luqmani, Richard A Watts
Multilevel factors predict medication adherence in rheumatoid arthritis: a 6-month cohort study
Alejandro Balsa, Maria Jesus GarcÃa de Yébenes, Loreto Carmona
Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database
Peter C Taylor, Tsutomu Takeuchi, Gerd R Burmester, Patrick Durez, Josef S Smolen, Walter Deberdt, Maher Issa, Jorge Ross Terres, Natalia Bello, Kevin L Winthrop
Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment
Karen Holten, Nina Paulshus Sundlisater, Siri Lillegraven, Joseph Sexton, Lena Bugge Nordberg, Ellen Moholt, Hilde Berner Hammer, Till Uhlig, Tore K Kvien, Espen A Haavardsholm, Anna-Birgitte Aga
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial
Andrew Östör, Filip Van den Bosch, Kim Papp, Cecilia Asnal, Ricardo Blanco, Jacob Aelion, Gabriela Alperovich, Wenjing Lu, Zailong Wang, Ahmed M Soliman, Ann Eldred, Lisa Barcomb, Alan Kivitz
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS)
Laura C Coates, Laure Gossec, Elke Theander, Paul Bergmans, Marlies Neuhold, Chetan S Karyekar, May Shawi, Wim Noël, Georg Schett, Iain B McInnes
Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort
Celline C Almeida-Brasil, John G Hanly, Murray Urowitz, Ann Elaine Clarke, Guillermo Ruiz-Irastorza, Caroline Gordon, Rosalind Ramsey-Goldman, Michelle Petri, Ellen M Ginzler, D J Wallace, Sang-Cheol Bae, Juanita Romero-Diaz, Mary Anne Dooley, Christine Peschken, David Isenberg, Anisur Rahman, Susan Manzi, Søren Jacobsen, Sam Lim, Ronald F van Vollenhoven, Ola Nived, Andreas Jönsen, Diane L Kamen, Cynthia Aranow, Jorge Sanchez-Guerrero, Dafna D Gladman, Paul R Fortin, Graciela S Alarcón, Joan T Merrill, Kenneth Kalunian, Manuel Ramos-Casals, Kristján Steinsson, Asad Zoma, Anca Askanase, Munther A Khamashta, Ian N Bruce, Murat Inanc, Michal Abrahamowicz, Sasha Bernatsky
Rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren’s syndrome shared megakaryocyte expansion in peripheral blood
Yukai Wang, Xuezhen Xie, Chengpeng Zhang, Miaotong Su, Sini Gao, Jing Wang, Changhao Lu, Qisheng Lin, Jianqun Lin, Marco Matucci-Cerinic, Daniel E Furst, Guohong Zhang
A unique circulating miRNA profile highlights thrombo-inflammation in Behçet’s syndrome
Giacomo Emmi, Giacomo Bagni, Elena Lastraioli, Francesca Di Patti, Alessandra Bettiol, Claudia Fiorillo, Matteo Becatti, Elena Silvestri, Maria Letizia Urban, Lorenzo Emmi, Domenico Prisco, Annarosa Arcangeli
Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumour necrosis factor inhibitors: data from register linkage of the NOR-DMARD study
Ingrid Egeland Christensen, Siri Lillegraven, Pawel Mielnik, Gunnstein Bakland, Liz Loli, Joe Sexton, Till Uhlig, Tore K Kvien, Sella A Provan
Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy
Nafise Ghalandari, Erik Kemper, Ineke (Hubertina) Crijns, Gertjan Wolbink, Theo Rispens, Hieronymus TW Smeele, Radboud JEM Dolhain
Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles
Vivian E Saper, Michael J Ombrello, Adriana H Tremoulet, Gonzalo Montero-Martin, Sampath Prahalad, Scott Canna, Chisato Shimizu, Gail Deutsch, Serena Y Tan, Elaine F Remmers, Dimitri Monos, Timothy Hahn, Omkar K Phadke, Elaine Cassidy, Ian Ferguson, Vamsee Mallajosyula, Jianpeng Xu, Jaime S Rosa Duque, Gilbert T Chua, Debopam Ghosh, Ann Marie Szymanski, Danielle Rubin, Jane C Burns, Lu Tian, Marcelo A Fernandez-Vina, Elizabeth D Mellins, Jill A Hollenbach, Drug Hypersensitivity Consortium
Importance of the second SARS-CoV-2 vaccination dose for achieving serological response in patients with rheumatoid arthritis and seronegative spondyloarthritis
Elisabeth Simader, Selma Tobudic, Peter Mandl, Helmuth Haslacher, Thomas Perkmann, Thomas Nothnagl, Judith Sautner, Helga Radner, Florian Winkler, Heinz Burgmann, Daniel Mrak, Daniel Aletaha, Stefan Winkler, Stephan Blüml
Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations
Féline P B Kroon, Aurélie Najm, Alessia Alunno, Jan W Schoones, Robert B M Landewé, Pedro M Machado, Victoria Navarro-Compán
Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19?
Hannah Bower, Thomas Frisell, Daniela Di Giuseppe, Bénédicte Delcoigne, Johan Askling
Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases
Francesco Ursini, Piero Ruscitti, Vincenzo Raimondo, Rossella De Angelis, Fabio Cacciapaglia, Erika Pigatto, Domenico Olivo, Ilenia Di Cola, Felice Galluccio, Francesca Francioso, Rosario Foti, Antonio Tavoni, Salvatore D'Angelo, Corrado Campochiaro, Francesca Motta, Maria De Santis, Silvia Bilia, Caterina Bruno, Giacomo De Luca, Marcella Visentini, Jacopo Ciaffi, Luana Mancarella, Veronica Brusi, Martina D’Onghia, Giovanna Cuomo, Enrico Fusaro, Lorenzo Dagna, Serena Guiducci, Riccardo Meliconi, Florenzo Iannone, Annamaria Iagnocco, Roberto Giacomelli, Clodoveo Ferri
Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2
Marcella Visentini, Laura Gragnani, Stefano Angelo Santini, Teresa Urraro, Annalisa Villa, Monica Monti, Andrea Palladino, Luisa Petraccia, Francesca La Gualana, Serena Lorini, Silvia Marri, Francesco Madia, Lucia Stefanini, Stefania Basili, Massimo Fiorilli, Clodoveo Ferri, Anna Linda Zignego, Milvia Casato
Safety and disease flare of autoimmune inflammatory rheumatic diseases: a large real-world survey on inactivated COVID-19 vaccines
Yong Fan, Yan Geng, Yu Wang, Xuerong Deng, Guangtao Li, Juan Zhao, Lanlan Ji, Xiaohui Zhang, Zhibo Song, Haoze Zhang, Xiaoying Sun, Dai Gao, Wenhui Xie, Hong Huang, YanJie Hao, Zhuoli Zhang
Higher serum levels of short-chain fatty acids are associated with non-progression to arthritis in individuals at increased risk of RA
Klara Martinsson, Kerstin Dürholz, Georg Schett, Mario M Zaiss, Alf Kastbom
When extended genetics rescues diagnosis: a patient with CANDLE-like phenotype and de novo mutation in the SAMD9L gene
Amandine Remy, Charlotte Borocco, Guillaume Sarrabay, Guilaine Boursier, Sylvie Fraitag, Benoit Catteau, Héloise Reumaux, Isabelle Koné-Paut
Challenges in optimising patient participation in research: do patients participating in meetings represent the actual patient population with Behçet’s syndrome?
Sıtkı Safa Taflan, Sinem Nihal Esatoglu, Yesim Ozguler, Berna Yurttas, Melike Melikoglu, Gulen Hatemi
Can sexual dimorphism in rheumatoid arthritis be attributed to the different abundance of Gardnerella?
Dongsong Liu, Feng Zhang, Hong Cao, Xuesong Wang
Response to: ‘Can sexual dimorphism in rheumatoid arthritis be attributed to the different abundance of Gardnerella?’ by Liu et al
Toshihiro Kishikawa, Yuichi Maeda, Takuro Nii, Yukinori Okada
Questions on ‘Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population’ by Guo et al
Cristina Regueiro, Antonio Gonzalez
Response to: ‘Questions on ‘Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population’ by Guo et al’ by Regueiro and Gonzalez
Jianping Guo, Tao Zhang, Xiaowei Li, Hongzhi Cao, Zhanguo Li
Reactive arthritis, a missing link: comment on the recent article from Sepriano et al
Henning Zeidler, Alan P Hudson
Response to: ‘Reactive arthritis, a missing link: comment on the recent article from Sepriano et al’ by Zeidler and Hudson
Alexandre Sepriano, Sofia Ramiro, Désirée van der Heijde, Robert B M Landewé
Secukinumab efficacy in patients with PsA is not dependent on patients’ body mass index
Ilenia Pantano, Daniela Iacono, Ennio Giulio Favalli, Giuseppe Scalise, Luisa Costa, Francesco Caso, Giuliana Guggino, Raffaele Scarpa, Francesco Ciccia
Prevalence of comorbidities and risk factors in spondyloarthritis: results of a cross-sectional study
Yupeng Lai, Yanpeng Zhang, Shaozhen Mo, Jinsheng Ma, Tongxin Ni, Zhihao Lei, Jun Xia, Chiduo Xu
Glucocorticoid withdrawal in lupus – to do or not to do?
Nupoor Acharya
Response to: ‘Glucocorticoid withdrawal in lupus: to do or not to do?’ by Acharya
Alexis Mathian, Micheline Pha, Zahir Amoura
Comments on the article: “Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial�
Mohammad Reza Mousavi, Erfan Taherifard
Response to: ‘Comments on the article: "Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial"’ by Mousavi and Taherifard
Alexis Mathian, Micheline Pha, Zahir Amoura
Immune-mediated necrotizing myopathies and interstitial lung disease are predominant characteristics in anti-Ku positive patients with idiopathic inflammatory myopathies
Hongxia Yang, Wenli Li, Xiaolan Tian, Guochun Wang, Xiaoming Shu, Qinglin Peng, Xin Lu
Response to: ‘Immune-mediated necrotizing myopathies and interstitial lung disease are predominant characteristics in anti-Ku positive patients with idiopathic inflammatory myopathies’ by Yang et al
Lionel Spielmann, Benoit Nespola, Alain Meyer
Efficacy of dupilumab reveals therapeutic target for IgG4-related disease: simultaneous control of inflammation and fibrosis
Motohisa Yamamoto, Noritada Yoshikawa, Hirotoshi Tanaka
MRI and ultrasonography are useful tools for a non-invasive diagnosis of IgG4-related disease
Augustin Lecler, Thomas Sené
Features of polymyalgia rheumatica–like syndrome after immune checkpoint inhibitor therapy
Gregoire Martin de Fremont, Rakiba Belkhir, Julien Henry, Anne Laure Voisin, Olivier Lambotte, Florent L Besson, Xavier Mariette, Gaetane Nocturne
